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1 ABSTRACT / ZUSAMMENFASSUNG 
Background: Point-of-care (POC) testing is the idea to measure rapidly 
biomarkers near patients. Nanotechnology offers a spectrum of new techniques 
that promise to revolutionize medicine. So-called passive microfluidic 
networks i.e. miniaturized channels that guide minute amounts of liquids 
across a surface are especially promising for a new generation of 
immunoassays, as they allow testing of a large number of analytes in a 
minimum of time with a minimum amount of reagents. The applicability of 
such devices to clinically important disease markers in human plasma samples 
has not yet been investigated.  
Aim: To investigate the feasibility, sensitivity, reproducibility of the 
micromosaic immunoassay (µMIA) to detect biomarkers in spiked human 
plasma samples. 
Method: We use passive microfluidic networks with 8 channels on a Si wafer 
to perform simultaneously up to 64 miniaturized solid phase immunoassays in 
a combinatorial fashion (i.e. one µMIA). These assays are distributed on a 180 
× 180 µm2 area and are analyzed by fluorescence microscopy. 
Results: We optimized the surface chemistry of the wafer, the capture and 
detection antibody concentrations, and the analyte incubation time. A µMIA 
can be performed within ~8 min. The sample volume required for multiple 
analyte detection is only ~2 µL. The detection limit for the cardiac marker C - 
reactive protein in human plasma is 0.03 µg mL-1. The intra-assay variance is 
4.4%. The quality of the assay pattern was analyzed. We also detected 
simultaneously five different cardiac markers in human plasma with one 
µMIA.   
Conclusions: This is the first experimental demonstration of the feasibility to 
detect proteins in human plasma with µMIAs. The reported sensitivity, 
reaction time, and intra-assay variance are better or equal to clinical laboratory 
testing. The results demonstrate the feasibility of µMIAs to measure 
biomarkers in human plasma samples and indicate the potential of µMIAs for 
laboratory and POC testing. 
 
Hintergrund: Point-of-care (POC) Testen ist der Ansatz, Biomarker in kurzer 
Zeit patientennah zu messen. Die Nanotechnologie bietet ein Spektrum neuer 
Techniken die versprechen, die Medizin zu revolutionieren. Sogenannt passive 
Microfluidic Networks, d.h. miniaturisierte Kanäle die kleinste 
Flüssigkeitsmengen über ein Oberfläche leiten, sind vielversprechend für eine 
neue Generation von Immunoassays, da sie Messungen einer Vielzahl von 
Proben in kurzer Zeit und mit einem Minimum an Reagentien ermöglichen. 
Die Anwendbarkeit dieser Technik für klinisch relevante Krankheitsmarker in 
menschlichem Plasmaproben wurde bisher noch nicht untersucht. 
Ziel: Die Zweckmässigkeit, Sensitivität, Reproduzierbarkeit des Micromosaic 
Immunoassays (µMIA) zur Messung von Biomarkern in gespiktem 
menschlichem Plasmaproben untersuchen. 
Methode: Wir verwenden passive ‚microfluidic networks’ mit 8 Kanälen auf 
einem Si Wafer zum gleichzeitigen Durchführen von bis zu 64 miniaturisierten 
heterogenen Immunoassays auf eine kombinatorische Art (d.h. ein µMIA). 
Diese Assays sind verteilt auf einer Fläche von 180 x 180 ym2 und werden per 
Fluoreszenzmikroskopie analysiert. 
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Resultate: Wir optimierten die Oberflächenchemie der Wafer, die 
Konzentrationen von ‚capture’ und ‚detection’ Antikörpern und die 
Inkubationszeit des Analyten. Ein µMIA kann innerhalb von ~8 min 
durchgeführt werden. Das notwendige Probevolumen beträgt nur ~2 µL. Die 
Detektionsgrenze des Herzmarkers C-reaktives Protein in menschlichem 
Plasma beträgt 0.03 µg mL-1. Die Varianz innerhalb eines µMIA beträgt 4.4%. 
Die Qualität des Depositionsmusters der Assays wurde untersucht. Wir 
bestimmten auch 5 verschiedene Herzmarker gleichzeitig mit einem µMIA. 
Schlussfolgerungen: Die gemessene Sensitivität, Reaktionszeit und Varianz 
innerhalb eines µMIA sind vergleichbar mit herkömmlichen Labormethoden 
und bestätigen ein Potential der µMIA in einem portablen Testsystem 
verwendet zu werden. 
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2  INTRODUCTION 
2.1 Point-of-Care Testing 
In recent time, a major interest of the fabrication of diagnostic instruments has 
been the miniaturization towards portability, simplicity of handling, reduction 
of time lapse from sample introduction to test result and the implementation of 
multiple clinical parameter determinations.1 This allows the displacement of 
measurements from a central laboratory directly to the bedside, which is called 
point-of-care (POC) testing or near-patient testing.2  The reason for this 
development is the urge to make rapid decisions in emergency triage of 
patients presenting with unspecific, but potentially life-threatening, symptoms. 
In emergencies, the transport of blood samples from the location of treatment 
to a laboratory can substantially increase the time to treatment. Besides 
diagnostics, the surveillance of stationary patients, especially of the critical 
care units, could also benefit from near-patient testing. Measuring crucial 
parameters in short intervals could contribute to a fast therapeutic intervention 
upon pathophysiologic events and a more accurate and specific treatment of 
disease states. Specifically designed test kits would allow the rapid availability 
of critical parameters.3 Difficulties with the integration and quality 
management of near patient testing outside laboratories with conventional 
standards have been stated.4 POC testing in performed in outpatient centres 
has also been mentioned as a survival strategy for American clinical 
laboratories, which are rivalled by more cost effective managed care 
organizations (MCOs).5 
A test kit specifically designed for the detection or exclusion of AMI could 
contain sensing areas for the following serum markers: C-reactive protein 
(CRP), myoglobin, cardiac Troponin-I (cTnI) or cardiac Troponin-T (cTnT) 
and D-Dimer.  
Point-of-care kits for Troponin already exist; they are mainly used in 
emergency stations. Many of them use a membrane-based immunoreaction, 
resulting in the visibility of a stripe of nano-gold particle derivatized 
antibodies indicating a positive result.6 It is the same principle used in 
pregnancy stripe tests that measure the beta-HCG content of urine. These tests 
are qualitative, only some are more elaborate and present semiquantitive 
results (usually tertile or quartiles of concentration). Generally, quantitative 
results are more desirable because they allow more accurate decision taking.   
                                                 
1
 Bingham D, Kendall J, Clancy M. The portable laboratory: an evaluation of the accuracy and 
reproducibility of i-STAT. Ann Clin Biochem. 1999; 36, 66. 
2
 Hudson MP, Christenson RH, Newby LK, Kaplan AL, Ohman EM. Cardiac markers: point 
of care testing. Clin Chim Acta. 1999; 284, 223. 
3
 Maisel AS, Koon J, Krishnaswamy P, Kazenegra R, Clopton P, Gardetto N, Morrisey R, 
Garcia A, Chiu A, De Maria A. Utility of B-natriuretic peptide as a rapid, point-of-care test for 
screening patients undergoing echocardiography to determine left ventricular dysfunction. Am 
Heart J. 2001; 141, 367. 
4
 Plebani M , Zaninotto M. Cardiac markers: centralized or decentralized testing? Clin Chem 
Lab Med. 1999; 37(11/12), 1113. 
5
 Takemura Y, Beck JR. Laboratory testing under managed care dominance in  the USA. J 
Clin Path. 2001; 54, 89. 
6
 Mueller-Bardorff M, Rauscher T, Kampmann M, Schoolmann S, Laufenberg F, Mangold D, 
Zerback R, Remppis A, Katus HA. Quantitative bedside assay for cardiac Troponin T: a 
complementary method to centralized laboratory testing. Clin Chem. 1999; 7, 1002. 
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2.2 Miniaturization of Bioassays 
Miniaturization of assays for determination of biological parameters in patient 
samples appears to be appealing because of reduced cost per result. Rapid 
analysis achieved in this way would also allow rapid therapeutic intervention.7 
However, the availability of an abundant amount of results is not always 
desirable, as the specificity of the tests will never reach hundred percent, and 
therefore false positive results will always be included, which will have to be 
further investigated, providing a source of unnecessary consumption of 
infrastructure and budget. Nevertheless, we are convinced of the advance of 
miniaturized test systems in the clinic. An effort to tailor the testing systems to 
clinical requirements has to be outperformed carefully in order to fully profit 
of facilitated data gain. Besides the health care sector, the pharmaceutical 
industry has a major interest in the availability of microscale assays for 
massively parallel drug discovery.8 Applications for toxicology are also being 
developed.9 An overview of current microarray technology and applications 
can be found in Kricka, 2001.10 
2.3 Microfluidic Networks 
In solid phase immunoassays (SPI), the limiting factor seems to be mass 
transport, which is driven by Brownian movement (diffusion). Efforts 
therefore tend towards miniaturization of wells in classical SPI, where one 
wants to reduce diffusion distance and thus minimize time required for 
saturation of surface. One problem encountered there is the increase of the 
quotient surface by volume, which can trouble saturation.11 Also commonly 
used are shakers in order to move the fluid in the wells to speed up mass 
transport by convection. The advantage of particle-based assays is their short 
reaction time for specific binding of analyte. The particles are entirely 
immersed in the fluid and they abide Brownian movement, they can therefore 
bind much more target molecules over time than a surface-immobilized 
antibody. Furthermore, there is no formation of a gradient towards the 
antibodies, as happens in standard SPI, where the analyte starts to become 
depleted in the intimate vicinity of the surface, thus contributing to the 
formation of large diffusion distances. Thus, incubation time for specific 
binding and blocking of the surface in standard SPI requires normally up to 
some hours. We describe the importance of the availability of rapid results in 
the clinic in the following section. Particle based immunoassays function most 
commonly with antibodies (or antigens) immobilized on latex particles. The 
change in turbidimetry and nephelometry can be measured by illumination 
with a laser and capture of the deviated light fraction by photo diodes.  
By means of the constant flow inside the channels and the micrometer range 
size, microfluidic networks provide both, small diffusion distances from bulk 
                                                 
7
 Kricka LJ. Miniaturization of analytical systems. Clin Chem. 1998; 9, 2008. 
8
 Rademann J, Jung G. Integrating combinatorial sythesis and bioassays. Science. 2000; 287, 
1947. 
9
 Rowe-Taitt CA, Golden JP, Feldstein MJ, Cras JJ, Hoffman KE, Ligler FS. Array biosensor 
for detection of biohazards. Biosensors and bioelectronics. 2000; 14, 785. 
10
 Kricka LJ, Fortina P. Microarray technology and applications: an all language literature 
survey including books and patents. Clin Chem. 2001; 8, 1479. 
11
 Silzel JW, Cercek B, Dodson C, Tsay T, Obremski RJ. Mass-sensing, multianalyte 
microarray immunoassay with imaging detection. Clin Chem. 1998; 9, 2036. 
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to surface and sufficient supply of molecules. They seem to be the ideal tool 
for rapid analysis (a few minutes), requiring only tiny amounts of solution 
(less than 500 nL). In Figure 1 the principle of the driving force of the flow in 
the channels, the contact angles of water with the surface, is demonstrated. 
Low contact angles correlate with fast filling. Laminar flow of a liquid in a 
capillary follows the equation 
 
      (1) 
 
The mean speed v of a liquid is proportional to the pressure drop, ∆p, driving a 
volume of liquid filling the channel over a length l. The factor Cg / η is a 
friction parameter, or dissipation term. Cg contains the geometric boundaries 
of the capillary and η is the viscosity. The pressure drop is described by 
 
   (2) 
 
where b is the width and a the height of the channels, γ the surface tension of 
the liquid and θPEG and θPDMS the contact angles of the liquid on PEG and 
PDMS respectively. The average contact angle of for thiol-PEGs is 40 deg 
whereas on thiol-ECT it is 110 deg. Ideal would be a contact angle of 0 deg 
inside the channels and of 180 deg outside the channels. Figure 2 shows the 
relation between depletion of proteins in the channels after 10 seconds and the 
size of the channels. The concentration gradient in small channels is larger for 
the distance from surface to the fast flowing region in the middle of the 
channel, which means, that rapid diffusion is sustained by rapid supply of 
molecules. In Figure 3, the velocity profile inside channels is shown in 
dependency of the distance passed from the entry port. 
 
 
Figure 1. Self-filling speed in perfectly wettable channel with a scheme of the contact angles 
in the channel. [fig. by D. Juncker] 
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Figure 2. Fraction of the adsorbed molecules after an incubation time of 10 s as a function of 
the distance of capillary walls. [fig. by D. Juncker] 
 
 
Figure 3. The X-axis represents the time in seconds, the y-axis the length l in mm. The filling 
speed decreases with increasing distance from the filling port, because resistance increases 
proportionally with length of the filled channel section. [Fig. by D. Juncker] 
 
Physisorption of proteins to a surface (non-specific binding) is a fast process. 
Its speed can be calculated by measuring the gradient of adsorbed proteins in 
protein-depleted channels (Figure 4). 
 
 
Figure 4. Low concentrations of proteins in solutions tend to deplete by surface adsorption 
with increasing distance from the filling port. The length of the depletion gradients can be 
used to calculate the adsorption time of proteins. [fig. from ref. 69] 
 
Physisorption takes place in some milliseconds and therefore is not a limiting 
factor in process speed. In contrast to NSA, specific binding of proteins 
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requires their proper orientation in order to expose their epitope to the variable 
region of the antibody or inversely. Estimations of the time required for proper 
formation of this bond and the time required for sufficient saturation (more 
than 95%) cannot be assessed by performing classical SPI, as their limiting 
factor is the mass transport of molecules. A time series to estimate the 
influence of binding kinetics on signal strength has been done. Its outcome is 
presented in the results section. 
2.4 Adsorption of Proteins from a Liquid to a Solid Phase 
The Scatchard model is the most widely used mathematical approach to the 
quantitative description of the multiple equilibriums taking place when a 
binder (e.g. an antibody) binds reversibly to a ligand molecule, L (antigen, 
analyte). 
 
      (4) 
 
The Scatchard Model focuses on the individual binding sites of the binder and 
applies the law of mass action for each site, s, defining the association constant 
(affinity constant) K and assuming that the affinity of each particular site for 
the ligand is not influenced by the extent of occupancy of the other sites 
(independent and non-interacting binding sites). Thus, 
 
     
 (5) 
 
where B and F represent the concentrations (molarities) of the bound and free 
(unbound) ligand respectively, and N is the total concentration of the binding 
sites. N is given by the product of the total binder concentration times the 
number of binding sites per binder molecule. N – B represents the 
concentration of unoccupied (free) binding sites on the binder molecule. 
However, protein functionality changes with adsorption on solid phases.12 
Upon adsorption, physical rearrangements in the conformation of proteins 
occur, depending both, on properties of the surface13 and of the protein density 
on the surface14 and of the electrolyte environment of the solution, due to co-
adsorption of electrolyte molecules.15 Steric hindrance and molecule 
orientation can trouble the proper exposure of bound molecule binding sites to 
the liquid phase. Furthermore, relative size of the analyte and the tracer (label) 
and the method of immobilization of the antibody influence the performance 
                                                 
12
 Butler JE, Ni L, Nessler R, Joshi KS, Suter M, Rosenberg B, Chang J, Brown WR, 
Cantarero LA. The physical and functional behaviour of capture antibodies adsorbed to 
polystyrene. J Imm Meth. 1992; 150, 77. 
13
 Elgersma AV, Zsom RLJ, Lyklema J, Norde W. Adsorption competition between albumin 
and monoclonal immuno-gamma-globulins on polystyrene lattices. J Colloid and Interface 
Science. 1992; 152, 410. 
14
 Wimalasena RL, Wilson GS. Factors affecting the specific activity of immobilized 
antibodies and their biologically active fragments. J Chromatography, Biomedical 
Applications. 1991; 572, 85. 
15
 Lyklema J. Proteins at solid-liquid interfaces, a colloid-chemical review. Colloids and 
Surfaces. 1984: 10, 33. 
sLLs ↔+
)( BNF
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−
=
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of immunoassays.16 Dynamic measurements reveal the non-uniformity of 
Langmuir curves with experimental data.17 Thus, these experimental data 
clearly indicate the limitations of the Scatchard model. Nevertheless, it is very 
useful for the approximate statistical evaluation of immunoassay dynamic 
range (performance). 
2.5 Non-Competitive, Solid Phase, ‘Sandwich’, Fluorescence Immuno-
assay 
The immunoassay binding makes profit of the specific binding of the variable 
region of antibodies (immunoglobulin G or IgG) to select regions (epitope) on 
a target molecule (antigen, analyte). Each antibody possesses two identical 
binding sites and therefore can potentially bind two antigens simultaneously.  
Antibody solutions can either be monoclonal or polyclonal. Antibodies are 
produced by plasma cells. Each plasma cell only produces antibodies with 
exactly the same binding specificity. To obtain solutions containing only 
antibodies of the same specificity, a single plasma cell is fused with spleen 
myeloma cells in order to enforce proliferation. Clone deriving of this cell will 
all produce structurally identical antibodies. Solutions of these are termed 
monoclonal. In contrast, polyclonal solutions derive from multiple plasma 
cells, as encountered in serum on physiological immune reaction. To isolate 
the fraction of analyte binding antibodies, affinity chromatography can be 
performed. The resulting solution will contain antibodies with identical 
binding specificity but differing binding constants. Monoclonal antibody 
solutions are therefore better suited for accurate quantitative measurements 
because they are well defined. An outline of the structure and functionality of 
antibodies and the immune system can be found in Janeway, 2000.18 
The binding of specific antibodies by the analyte can be made detectable 
among other by labelling the antibodies with a signal molecule whose 
concentration can be quantified by radiometry, fluorescence, reflectance or 
luminescence (corresponding to radioisotope, fluorophore, metal particles, 
enzymes as labels). In Figure 5, the principle of the sandwich immunoassay is 
demonstrated. A capture antibody is immobilized on a solid phase (surface). 
The remaining free area of the surface is blocked by adsorption of BSA or 
casein to prevent non-specific adsorption of analyte or detection antibody. The 
surface is then incubated with analyte solution. The capture antibody binds the 
analyte. The surface is rinsed and detection antibody solution is added. 
Detection antibodies will bind to the bound analyte, and consecutively 
allowing the determination of their surface density which is proportional to the 
amount of analyte in the analyte solution (given that saturation of capture 
antibodies with analyte has not been reached). 
 
                                                 
16
 Schramm W, Paek SH. Antibody-antigen complex formation with immobilized 
immunoglobulins. An Biochem. 1992; 205, 47. 
17
 Bernard A, Bosshard HR. Real-time nonitoring of antigen-antibody recognition on a metal 
oxide surface by an optical grating coupler sensor. Eur J Biochem. 1995; 230, 416. 
18
 Janeway C, Travers (Eds.). Immunobiology, Current Biology Ltd., London, 2000. 
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Figure 5. Principle of the sandwich immunoassay. The solid black spots on the detection 
antibody symbolize label molecules (BSA: bovine serum albumin). 
 
An outline of the development of ligand assays can be read in Ekins, 1998.19 
Further reading on immunoassays can be found in Diamandis, 1996.20 
2.6 C-reactive Protein 
C-reactive protein (CRP) consists of five identical non-glycosylated subunits 
and has a molecular weight of 23.0 kD. It is part of the pentraxine protein 
group, found in all vertebrates and most non-vertebrates. CRP is synthesized 
in the liver upon stimulation with IL-6 (interleukin 6), a signal substance of 
the leucocytes.21 Its concentration in adults and children is 0.068 – 8.2 mg L-1, 
with a median of 0.58 mg L-1.22,23(higher values are reported in a recent 
study),24 where age and female sex contribute to slightly raised values.25 The 
serum level of CRP increases within 6 hours after a trauma and reaches its 
peak after 48 hours.26 An inflammation produces raised levels of CRP 
(although not necessary, as e.g. for Colitis ulcerosa).27 The clinical threshold 
has been set to 10 mg L-1, values greater than 100 mg L-1 can be observed in 
systemic bacterial inflammations, where sepsis with gram-negative bacteria 
produces levels up to 500 mg L-1. Its main role remains uncertain. As no 
genetic variation of its gene has been observed, it is most probably essential 
for vertebrate life. Some functions include binding to endogenous and 
exogenous ligands in the presence of calcium, e.g. particle of necrotic cells, to 
                                                 
19
 Ekins RP. Ligand assays: from electrophoresis to miniaturized microarrays. Clin Chem. 
1998; 9, 2015. 
20
 Diamandis EP, Christopoulos TK (Eds.) Immunoassay. Associated Press, New York, 1996. 
21
 Weinhold B, Ruther U. Interleukin-6-dependent and –independent regulation of the human 
C-reactive protein gene. Biochem J. 1997; 327, 425. 
22
 Marhaug G, Dowton SB. Serum amyloid A: apolipoprotein and precursor of AA amyloid. 
In: Husby G, ed. Reactive Amyloidopsis and the Acute Phase Response. Ballieres Clinical 
Rheumatology, Vol 8, no. 3, Ballierer Tindall, London, 1994; 533. 
23
 Kindmark CO. The concentration of C-reactive protein in sera from healthy individuals. 
Scand J Clin Lab Invest. 1972; 29, 407. 
24
 Price CP, Calvin J, Walker SA, Trull A, Newman DJ, Gorman EG. A rapid and sensitive 
automated light scattering immunoassay for serum C-reactive protein and the definition of a 
reference range in healthy blood donors. Clin Chem Lab Med. 1999; 37(2), 109. 
25
 Hutchinson WL, Koenig W, Froehlich M, Sund M, Lowe GDO, Pepys MG. 
Immunoradiometric assay of circulating C-reactive protein: age-related values in the adult 
general population. Clin Chem. 2000; 7, 934. 
26
 Colley CM, fleck A, Goode AW, Muller BR, Myers MA. Early time course of the acute 
phase response in man. J Clin Pathol. 1983; 36, 203. 
27
 Tillet WS, Francis T. Serological reactions in pneumonia with a non-protein somatic 
fraction of pneumonococcus. J Exp Med 1930; 52, 561. 
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cell membranes with defect lipid bilayer presenting internal phospholipids, 
phosphorylcholin from cell membranes of bacteria, fungus and parasites. It can 
contribute to their elimination by opsonisation. Bound to a ligand it can 
activate the complement system over the classical pathway, bind directly to 
receptors (FcXR1) on phagocytes and lymphocytes (IgG-FcR), and precipitate 
ligands.28 The time course of CRP serum levels after myocardial infarction has 
been proposed as an independent prognostic marker after AMI.29,30 In recent 
times, the correlation between atherosclerotic plaques and elevated levels of 
CRP has been investigated on its usability as a prognostic marker in future 
atherosclerotic lesions, especially in the coronary arteries.31 It has been 
observed, that raised levels of CRP correlate with an increased risk of 
succumbing AMI by vessel occlusion. Association of pre-treatment CRP 
levels with unstable angina and specific high risk features of coronary lesions 
determined with coronary angiography has been shown.32,33 CRP as a strong, 
independent predictor of future coronary events, comparable to the prognostic 
significance of serum LDL values, has been proposed.34 Consistency of these 
findings has been demonstrated in meta-analysis of prospective studies.35,36 
Intraindividual diurnal variation of CRP levels in healthy subjects has been 
shown to be neglectable when quintiles of CRP levels are used for clinical 
assessment, whereas IL-6 shows significant variations.37 Some authors point 
out the questions arising from the significant fall of CRP levels upon initiation 
of treatment with statins (HMG-CoA reductase inhibitors) significantly before 
their action on the serum lipid metabolism on the possible mechanism of their 
                                                 
28
 Agrwal A, Kilpatrick JM, Voanakis JE. Structure and function of human C-reactive protein. 
In: Mackiewicz A, Kyshner I, Baumann H, eds. Acute phase proteins. London: CRC Press, 
1993, p79. 
29
 De Winter RJ, Fischer JC, de Jongh T, van Straalen JP, Bholasingh R, Sanders GTB. 
Different time frames for the occurrence of elevated levels of cardiac Troponin T and C-
reactive protein in patients with acute myocardial infarction. Clin Chem Lab Med. 2000; 
38(11), 1151. 
30
 Roberts WL, Sedrick R, Moulton L, Spencer A, Rifai N. Evaluation of four automated high-
sensitivity C-reactive protein methods: implications for clinical and epidemiolocigal 
applications. Clin Chem. 2000; 4, 461. 
31
 Van Lente F. Markers of inflammation as predictors in cardiovascular disease. Clin Chim 
Acta. 2000; 293, 31. 
32
 Koenig W, Sund M, Froehlich M, Fischer HG, Loewel H, Doering A, Hutchinson WL, 
Pepys MB. C-reactive protein, a sensitive marker of inflammation, predicts future risk of 
coronary heart disease in initially healthy middle-aged men. Circulation. 1999; 99, 237. 
33
 Katritis D, Korovesis S, Giazitzoglou E, Parissis J, Kalivas P, Webb-Peploe MM, Ioannidis 
JPA, Haliassos A. C-reactive protein concentrations and angiographic characteristics of 
coronary lesions. Clin Chem. 2001; 5, 882. 
34
 Rifai N, Ridker PM. High-sensitivity C-reactive protein: a novel and promising marker of 
coronary heart disease. Clin Chem. 2001; 3, 403. 
35
 Danesh J, Collins R, Appleby P, Peto R. Association of fibrinogen, C-reactive protein, 
albumin, or leukocyte count with coronary heart disease. JAMA. 1998; 279, 1477. 
36
 Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby P, Gallimore RJ, Pepys 
MB. Low grade inflammation and coronary heart disease: prospective study and updated 
meta-analyses. BMJ. 2000; 321, 199. 
37
 Meier-Ewert HK, Ridker PM, Rifai N, Price N, Dinges DF, Mullington JM. Absence of 
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action.38 Standardization of high sensitivity automated assays is a topic of 
concern,39 as in general is the immunoassay standardization.40 
2.7 Pathophysiology of Acute Myocardial Infarctions 
When a blood vessel is obstructed (this commonly happens in acute 
myocardial infarction (AMI) by embolism, when a thrombus, usually from the 
left atrium, is swept to the periphery, or rupture of an atherosclerotic plaque 
inside the coronary vessel) no blood can reach the tissue beyond this point if 
there is no other vessel distributing to the same region. This state is called 
ischemia. The most affecting factor is the absence of oxygen supply, resulting 
in hypoxia.  Energy formation in myocardial cells is driven by oxygenation of 
free fatty acids. Upon hypoxia, anaerobic energy formation fills the gap until 
the environment is saturated with lactic acid. The most important cellular 
energy transporter is the molecule ATP (adenosinetriphosphate). Energy 
dependent processes, as for example the maintenance of ionic gradients across 
cell membranes will stop on depletion of ATP. Change of ionic composition 
inside cells is a major contributor to the initiation of cellular necrosis 
processes. Autolysis takes place by activation of intracellular enzymes, and 
decomposition of cell membranes. Intracellular proteins (myoglobin, troponin) 
leak through defect endothelia and can be detected in the blood.41 Research on 
the accuracy and standardization of these biochemical markers of myocardial 
infarction has been very prodigious in the last ten years and it has been 
addressed as a cover topic in journals dealing with clinical chemistry.42 The 
search for more specific, sensitive, and immediately responding serum 
markers is still going on.43 Myoglobin can already be detected 2 – 6 hours 
after a coronary occlusion, but it is not specific to the heart, since it exists also 
in skeletal muscle cells. Troponin can be detected later but has a heart specific 
isoform, which can be distinguished with the proper antibodies (in this case 
patented by Hoffmann-La Roche). CRP is a general indicator of inflammatory 
processes (see the following section). D-dimers are a standard indicator for 
blood clotting processes in the past few hours. They are a cleavage product of 
fibrin and could be used as a sensitive but not specific marker for exclusion of 
pneumonic embolism, which can present the same symptoms as AMI.  
2.8 Contact Angle Goniometry 
Contact angle goniometry is a technique to evaluate the wetting properties of a 
substrate by measuring the angle of the shape profile of a drop that is formed 
by a liquid on a surface of interest. If the liquid does not wet the surface 
                                                 
38
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 Stenman UH. Immunoassay standardization: Is it possible, who is responsible, who is 
capable? Clin Chem. 2001; 47, 815. 
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ikin IhE −= ν
completely (Θ = 0) one can measure an angle, which is termed the angle of 
contact. The equilibrium of such systems can is described by Young’s 
equation. The experimental setting used for this work measures angles of 
captive drops. A small volume of liquid is placed on the surface, the advancing 
contact angle Θa is measured, a portion of this volume is aspired again and the 
receding contact angle Θr is measured. The difference ∆cos(Θ) = cos(Θr) – 
cos(Θa) is termed hysteresis and is an important indicator for the homogeneity 
of the surface.44 
2.9 X-Ray Photoelectron Spectroscopy 
X-Ray photoelectron spectroscopy (XPS) is a convenient method for a precise 
investigation of the chemical composition of surfaces.45 This method relies on 
the ejection of electrons from surface atoms by X-rays (photons with high 
energy). 
 
 
Figure 6. Principle of photoelectron spectroscopy. (A) An incoming photon ejects an electron 
from its orbital. (B) Basic components of an XPS and their arrangement. [fig. by M. Geissler] 
 
Electrons ejected by the photoelectric effect are called photoelectrons. The 
kinetic energy Ekin of the photoelectrons corresponds to the difference between 
the energy hν of the incoming X-ray photons and the ionization energy Ii, 
which is required to remove an electron from the orbital i of an atom. This 
correlation can be expressed by the following equation, 
 
 (3) 
 
where h is Planck’s constant, and v is the frequency of the X-rays. In XPS, the 
kinetic energy of the photoelectrons is measured: for a given energy of the 
photons, the detected kinetic energies of the photoelectrons can be used to 
calculate the core level binding energies (corresponding to Ii) of an atom. The 
                                                 
44
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45
 Carson TA. Photoelectron and Auger Spectroscopy, Plenum Publishing Co, New York, 
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atomic identification of elements is possible with this method, because every 
element has a specific set of core levels and binding energies. Changes in the 
oxidation state of an element affect local binding energy states, which results 
in “chemical” shifts of the kinetic energy of the photoelectrons. This effect can 
provide useful information about the chemical environment of an element.46 In 
principle, the quantification of a measurement is possible by using peak area 
and peak height sensitivity factors which have been established for individual 
signals of several elements. XPS measurements are performed in ultra-high 
vacuum (UHV) at a pressure of ~10-9 mbar and they usually require a complex 
and expensive setup. A simplified scheme of an X-ray photoelectron 
spectrometer is shown in Figure 6. A monochromatized beam of photons 
produced in the X-ray source (often used is an AlKα source, E = 1486.6 eV) 
interacts with the sample. The photoelectrons ejected from the sample are 
collected as a function of their kinetic energy by a hemispherical analyzer. The 
pass-energy selector terminating the analyzer modulates the energy dispersion 
around a selected energy (which mainly determines the resolution and the 
sensitivity of a measurement). A channel plate detector finally transforms the 
electronic flow into signals, which can be digitized and converted into a 
spectrum. 
2.10 Ellipsometry 
Ellipsometry is a fast and inexpensive method to characterize films thinner 
than15 nm on a supporting substrate and to determine their thickness. Plane-
polarized light impinges at a defined angle of incidence on the surface of a 
substrate (Figure 7). The reflected beam is elliptically polarized. The ratio of 
amplitudes of the two components of the light together with its phase shift are 
relate to the thickness ts and the complex refractive index (Ns = ns + ks i) of the 
substrate. A thin film deposited on the substrate changes the reflected 
polarized light depending on the refractive index nf and the thickness tf of the 
film . As it is not possible to determine both refractive index and thickness 
simultaneously, values of the refractive index of such films are set or assessed 
beforehand.47 For protein layers, nf is estimated to be 1.45 at 645 nm. 
Ellipsometry can be used to measure accurately biomolecule layers on 
reflective supports and to detect binding events on these molecules by 
measuring the change in thickness.48 A 0.05 increase of nf induces a 0.1 nm 
decrease of the calculated thickness. Ultrasensitive immunoassays for hepatitis 
B surface antigen and alpha-fetoprotein using this principle have been 
constructed.49 
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1977. 
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Figure 7. In Ellipsometry, a laser beam is reflected on the substrate. [fig. by A. Bernard] 
2.11 Affinity Chromatography 
In conventional liquid chromatography, unspecific chemical interactions due 
to physical properties of the passing molecules (size, charge, polarity) induce 
different retention times, which induce the separating process.50 Affinity 
chromatography, in contrast is based on the specific interaction between a 
target molecule and a solid phase ligand (Figure 8). If desired, elution of the 
bound analyte can be achieved by rinsing with low pH or high ionic strength, 
depending on the nature or the binding. 
 
 
Figure 8. A specific binding behaviour is used in affinity chromatography. [fig. by A. 
Bernard] 
2.12 Polydimethylsiloxane 
Poly(dimethylsiloxane) (PDMS) can be polymerized from its precursors either 
thermally with a platinum catalyst or under UV light with a radical initiator. 
Figure 9 outlines the chemistry of the polymerization process. The principle 
characteristics of PDMS are listed in Table 1.  
 
                                                 
50
 Porath JJ. Metal-ion hydrophobic, thiophilic and II-electron governed interactions and their 
applications to salt-promoted protein adsorption chromatography. Biotechnol Progress. 1987; 
3, 14. 
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 Forms conformal contact  
 Deformable 
 Low interfacial free energy: 21.6 10-3 Jm-2 
 Chemically inert 
 Homogeneous, isotropic, optically transparent (< 300 nm) 
 Durable 
 Surface derivatization possible (O2-Plasma, SAM) 
 
Table 1. Some properties of PDMS.51 
 
 
Figure 9. Reaction educts and polymerization reaction of poly(dimethyl)siloxane (PDMS). 
[fig. by A. Bernard] 
2.13 Self-Assembled Monolayers of Thiols on Gold 
Self-assembled monolayers (SAMs) can be formed by immersion of a gold 
surface into a solution of alkanethiols and have been well characterized.52,53,54 
                                                 
51
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54
 Delamarche E, Michel B, Kang H, Gerber C. Golden interfaces: The surface of self-
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Formation of the monolayers occurs by chemisorption of the sulphur atom to 
the gold surface with high affinity and stability (Au-S: dG ~ 40 kcal mol-1, half 
the value of a C-C bond).55 Figure 10 shows the tilted arrangement of the 
alkane chains on the surface.  
 
HS
Thiols in
solution
S S S S S
SAM (Side view)
S
0.288 nm 0.501 nm
A B
XX X X X
SH
XX
SAM on Au(111)
(Top view)
30°
X(CH ) SH  +  Au                 X(CH ) S  Au  +  1/2 H2 n 2 n 2
– + 
 
Figure 10. (A) Single thiol molecules are twisted in solution. Upon adsorption on gold, a 
regular, tilted arrangement appears. (B) The areal density of the thiol molecules in comparison 
with the atomic view of the gold surface. [fig. by M. Geissler] 
 
Different terminating groups of the alkanethiols allow formation of 
monolayers with varying chemical and physical properties (e.g. wettability). A 
topic of major interest is the generation of biocompatible surfaces (implants, 
food industry, ship construction).56 Monolayers of alkanethiols with a whole 
spectrum of different ω-groups have been investigated on their wettability and 
resistance to adsorption of proteins and detergents.57,58,59,60 Efforts were made 
to relate protein and detergent adsorption on thiol-SAMs to the surface 
wettability of the SAMs.61 Mobility and aggregation of proteins and their 
interaction with SAMs also depend strongly on the chain length of the bound 
alkane chains.62 Polyethyleneglycol resists the adsorption of proteins.63,64,65 
                                                 
55
 Whitesides GM, Laibinis PE. Wet chemical approaches to the characterization of organic 
surfaces: Self-assembled monolayers, wetting, and the physical-organic chemistry of the solid-
liquid interface. Langmuir. 1990; 6, 87. 
56
 Chapman RG, Ostuni E, Liang MN, Meluleni G, Kim E, Yan L, Pier G, Warren HS, 
Whitesides GM. Polymeric thin films that resist the adsorption of proteins and the adhesion of 
bacteria. Langmuir. 2001; 17, 1225. 
57
 Sigal GB, Mrksich M, Whitesides GM. Using surface plasmon resonance spectroscopy to 
measure the association of detergents with self-assembled monolayers of hexadecanethioate 
on gold. Langmuir. 1997: 13, 2749. 
58
 Chapman RG, Ostuni E, Yan L, Whiteside GM. Preparation of mixed self-assembled 
monolayers (SAMs) that resist adsorption of proteins using the reaction of amines with a SAM 
that presents interchain carboxylic anhydride groups. Langmuir. 2000a; 16, 6927. 
59
 Holmlin RE, Chen X, Chapman RG, Takayama S, Whitesides GM. Zwitterionic SAMs that 
resist nonspecific adsorption of protein from aqueous buffer. Langmuir. 2001; 17, 2841. 
60
 Chapman RG, Ostuni E, Takayama S, Holmlin RE, Yan L, Whitesides GM. Surveying for 
surfaces that resist the adsorption of proteins. J Am Chem Soc. 2000b; 122, 8303. 
61
 Sigal GB, Mrksich M, Whitesides GM. Effect of surface wettability on the adsorption of 
proteins and detergents. J Am Chem Soc. 1998; 120, 3464. 
62
 Yang Z, Galloway JA, Yu H. Protein interactions with poly(ethylene glycol) self-assembled 
monolayers on glass substrates: diffusion and adsorption. Langmuir. 1999; 15, 8405. 
63
 Bailey FE, Koleske Jy. Poly(Ethylene Oxide), Academic Press, New York, 1976. 
64
 Harris JM, Zalipsky S. Poly(ethylene glycol). Chemistry and Biological Applications. 
American Chemical Society, Washington DC, 1997. 
INTRODUCTION   17 
Marc Wolf – 2003 
and of many detergents .57 A simple method to print alkanethiols on gold 
surfaces with a stamp of PDMS was developed, which allows structured 
derivatization of gold surfaces.66,67 
Thiol-SAMs on gold thus provide a means to define surface properties like 
contact angle and control of protein adsorption in a well-defined and 
structured manner.68 
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3 EXPERIMENTAL SECTION 
3.1 Solid Phase Substrate 
PDMS serves as the solid phase substrate and it was obtained by curing the 
prepolymer components of Sylgard 184 (Dow Corning, Midland, MI) at 60º C 
for at least 24 h between the bottom of a polystyrene dish and a plan parallel 
flat piece of glass. Subsequently the substrate was cut to the desired 
dimensions (2 × 3 mm2). 
3.2 Fabrication of Microfluidic Networks  
Standard photolithography was used to pattern microchannels and pads in Si 
wafers. The wafers were first spin-coated at 4000 rpm with ~1.2 µm of 
AZ6612/H2O (1:4; Hoechst), photoexposed through a Cr mask (Photronics, 
Dresden, Germany) and developed for 30 s in AZ400/H2O (1:4; Hoechst). The 
photoresist acted as a mask for an inductively coupled plasma (reactive ion 
etcher from Surface Technology Systems, Cambridge, U.K.) to pattern the 
silicon wafer. The geometry of the µFN consisted of sixteen 1.5 × 1.5 mm2 
pads connected by eight 20 µm wide channels. Channels and pads both had a 
depth of 20 µm. 
3.3 Surface Preparation of the Silicon Wafer 
The silicon wafers were put under a UV lamp (UV-Ozone Photoreactor PR-
100, Ultra-Violet Products, Upland, CA) for 15 min and rinsed with Ethanol. 
A flat piece of PDMS, sufficiently large to cover the wafer with the µFNs, was 
rinsed with Ethanol for 2 s and was dried under a stream of N2. A sufficient 
amount of 0.3 mM solution of Eicosanethiol (Robinson Brothers, West 
Bromwich, West Midlands, US) in Ethanol to cover entirely the PDMS 
surface was deposited for at least 30 s (Figure 11A). The substrate was then 
dried under N2 and put on the wafer for at least 20 s to allow establishment of 
conformal contact (Figure 11B). Thus, formation of a hydrophobic Au-ECT 
SAM sparing the channels and pads was formed (Figure 11C). Covering the 
channels with a hydrophilic layer of PEGs was achieved by immersion of the 
µFNs in a 10 mM solution of a Poly(ethylene)glycol with the structural 
formula of CH3O-POEx-NH-CO(CH2)2-SH (Rapp Polymere, Tuebingen, 
Germany) in Ethanol (Figure 11D). The functionalized wafer is wettable 
inside the channels (PEG) and pads and non-wetting on the surrounding 
surface (ECT), Figure 11E. 
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Figure 11. Production of wetting channels and repelling surroundings. (A) A flat piece of 
PDMS is incubated with a solution of Eicosanethiol (ECT). (B) The gold coated wafer with 
the capillary structure is put on this piece of PDMS. The ECT molecules are thus selectively 
printed on the channel spacing. (C) The resulting monolayer of ECT on the wafer. (D) The 
wafer is incubated with a solution of poly(ethylene)glycol (PEG). The PEG molecules adsorb 
preferentially on the ECT-free gold surface. (E) The resulting thiol monolayer pattern with 
regionally differing wetting properties. 
3.4 Surface Characterization of the Silicon Wafer 
XPS spectra were acquired on a Sigma Probe VG Scientific spectrophotometer 
operation at a base pressure of ≤10-9 mbar and equipped with a 
monochromatized Al Kα source (E = 1486.6 eV). The X-ray spot was focused 
down to 400 µm in diameter. The analyzer had an angle of 37 º to the sample. 
Samples were mounted on a multisample holder stage for examination under 
the same conditions. Spectra are referenced to the Au 4f5/2 peak at 84 eV. For 
all samples survey spectra were acquired first with a pass energy of 80 eV (0.4 
eV steps for 40 ms) and high-resolution spectra for N 1s, O1s, C1s were taken 
with a pass energy of 40 eV (0.05 eV steps for 100 ms). The electron beam 
used to generate the X-rays had in all cases an intensity of 13 mA, which 
remained stable within <5% during the experiments. The intensity of the peaks 
from the substrates die not vary noticeably during the experiments, which 
indicated no particular damages on the surfaces of the grafted samples during 
the measurements.  
Wettability of the modified surfaces by water was determined using a Kruess 
contact angle goniometer (Hamburg, Germany) equipped with a motorized 
pipette (Matrix Technology, Nashua, NH). Advancing and receding angles 
were measured at multiple distinct locations on each sample.  
Ellipsometry was used to measure the change in monolayer coverage of the 
gold samples. For this purpose, a Rudolph AutoEL automatic thin-film 
ellipsometer equipped with a 632.9 nm He-Ne laser and operating at an angle 
of incidence of 70 º has been used. The polarizer angle was 45 º. The complex 
refractive index of the gold substrate, Ns = ns + ksi, was measured first. The 
thickness of the SAMs was measured at precise locations (∆ <0.5 mm), where 
ns and ks were recorded. The instrument was calibrated by measuring a series 
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of SAMs of alkanethiols (CH3(CH2)n-1SH, n = 2, 4, 6, 8, 12, 14, 16, 18, 20) on 
Au having known thicknesses. For this series of thiols a refractive index of nf 
= 1.45 was used. The accuracy was ±0.1 nm using this method.  
3.5 Chemicals and Biochemicals 
Ethanol (Fluka Chemie, Buchs, Switzerland) was used. When stated dH2O it 
stands for deionised water purified with a Millipore Simplicity 185 (Millipore 
S.A., Molsheim, France) filtering device with purity grade of 18.2 MΩ was 
used. Drying under a stream of N2 was performed using gas emanating from 
liquid N2. 
Prepacked phosphate buffered saline (PBS) from Pierce Chemicals (Rockford, 
IL) with pH 7.2, 0.1 M sodium phosphate and 0.15 M sodium chloride was 
prepared with Millipore H2O. Bovine serum albumin, BSA (Sigma Chemicals, 
St. Louis, MO) was diluted in PBS to a working concentration of 10 mg mL-1. 
Human blood was extruded with S-Monovettes (Sarstedt) containing Li-
Heparin for a final concentration of 15 IE mL-1 of blood. The plasma fraction 
was separated by double centrifugation at 5500 rpm for 10 min equivalent to a 
force of 2000 times earths gravity (Eppendorf Centrifuge 5415 D). 
Monoclonal antibodies αhCRP (mouse IgG1, clone C2) αhCRP FITC 
conjugate (mouse IgG2a, clone C6), anti-human cardiac myoglobin (mouse 
IgG1, clone 7C3), anti-human cardiac myoglobin FITC conjugate (mouse 
IgG1, clone ) and antigens CRP, myoglobin used were obtained in PBS 
solution with 0.1 % sodium azide as a preservative (Hytest, Turku, Finland). 
For affinity purification of human plasma 10 mg of protein A coated sepharose 
(Sigma Chemical, St. Louis, MO) were incubated for one hour at room 
temperature on a shaker with 200 µL of a solution of rabbit polyclonal αCRP 
which was obtained in lyophilized form (Anawa Trading, Wangen, 
Switzerland) and diluted in 1 mL PBS following the manufacturers 
recommendations. Separation of unbound immunoglobulins was accomplished 
by repeated centrifugation for 2.5 min at 13200 rpm, discarding of fluid 
fraction and redistribution in PBS on a vortex for at least seven times. The 
functionalized sepharose was incubated with 1 mL of human plasma for one 
hour at room temperature on a shaker and eventually separated again by 
centrifugation. Human plasma did not produce a signal that was discernable 
from the  background signal in microfluidic immunoassays.  
3.6 Image Acquisition 
Images were acquired with a ST-8 CCD (SBIG, Santa Barbara, CA) mounted 
on an epifluorescence microscope (Nikon Labophot-2) with a filter set 
consisting of 465 - 495 nm excitation, 505 nm dichroic mirror and 515 - 555 
nm emission (Nikon FITC) and a xenon arc lamp (Osram, XBO 100W OFR). 
Skypro software (Software Bisque, Golden, CO) was used for data acquisition 
and visualization. Exposure integration time was 16 s with 4 fold attenuation 
by insertion of a neutral density filter into the excitation path. Quantitative 
analysis was performed with a program written in LabView by Bruno Michel. 
Inhomogenous illumination field and substrate autofluorescence was 
accounted for as in, 
 
      (6) 
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where s* is the raw signal data, b the constant background (introduced by 
SkyPro software and physically by external stray light) and a the 
autofluorescence signal of the substrate, obtained by measurement. 
Calculations are averaged on spots of 16 x 16 pixels as standard deviation is 
kept lower thus than with pixel by pixel operation. The data was graphically 
interpreted with Origin 6.0 (Microcal). 
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4 RESULTS 
4.1 Patterned Delivery of Proteins with Microfluidic Networks 
By putting a flat substrate of PDMS on top of a capillary network in silicon, 
small capillaries are formed. Width and depth of the capillaries used for our 
experiments in this work were 20 x 20 µm2. The driving forces to fill the 
capillaries are solely capillary forces. Filling with solutions of proteins enables 
accurate delivery to specific regions on the substrate surface and has already 
been described.69,70 Application of this technique to produce immunoassays 
has been demonstrated.71 The basic principle of combinatorial microfluidic 
immunoassays, the micromosaic immunoassays, is shown in Figure 12. 
 
 
Figure 12. Patterning surfaces with proteins using microfluidic networks. (A) The element 
with the channels are put on top of a flat substrate. The resulting capillaries are filled with 
capture antibody solution. The proteins adsorb to the substrate surface. The channels are 
flushed with a blocking solution (BSA). (B) The element is taken away and the entire 
substrate is blocked. (C) The element is put on the substrate, with the channels orthogonal to 
the direction they had in the first step. Samples are introduced into channels and analyte binds 
to capture antibody. Channels are rinsed with blocking solution. Detection antibody solution is 
filled in. Channels are rinsed again with blocking solution. (D) The microfluidic network is 
taken off, and fluorescence microscopy reveals a pattern which can be analysed. [fig. by A. 
Bernard] 
 
A typical pattern of fluorescent microspots is produced with a µMIA and can 
be detected with a fluorescence microscope (Figure 13). 
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Figure 13. Different solutions can be inserted into the 8 individual channels. Thus, a 
maximum of 64 single fluorescent spots can be obtained. (A) Schematized representation of 
the resulting pattern of a micromosaic immunoassay. (B) Picture obtained by fluorescence 
microscopy of a micromosaic pattern. The two different colours represent different signals of 
two different tags on the same substrate, whose signal has been superimposed in this picture. 
[fig. from ref. 71] 
 
A flow promoting sheet of nylon put atop the exit pads of the microfluidic 
network can soak up the liquids from the exit pads. Thus, the entire volume of 
liquid filled into the loading pads passes through the microchannels. The 
loading pads become empty again and they can be refilled with a different 
liquid without removal of the PDMS substrate (Figure 14). 
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Figure 14. Method for exposing a PDMS substrate to solutions using a µFN. (A) A solution 
placed on the pad of a microfabricated µFN flows through the microchannel and into a flow-
promoting structure because of capillary forces. (B) This photograph shows a block of PDMS 
placed over the microchannels of the µFN, which serves as the substrate for the immunoassays 
performed in this work. (C) Loading solutions consecutively into the same pad is denoted 
throughout this publication with arrows: Each arrow corresponds to an elementary step 
(filling, rinsing, blocking, etc.); compounds in the solution are indicated above the arrow, their 
concentration and the duration of the step below. Here, the two arrows refer to (D), in which 
all eight independent pads are loaded sequentially with a red and a blue solution. The 
absorbing tissue after the PDMS block provides both the capillary pump and waste element of 
the µFN. 
4.2 Working Procedure of a Micromosaic Immunoassay 
The 8 channels of a freshly prepared µFN were covered with a piece of 
PDMS. A humidity chamber was set up, containing a heater plate constantly 
keeping a beaker with water at a temperature around 65 °C to generate a 
relative humidity varying between 85 and 95 %. The channels of the µFN were 
filled and rinsed in this ambient in order to keep evaporation at a minimum 
level. First, 100 µL of PBS were placed on one side of substrate and were 
allowed to fill the channels. A piece of clean room paper with strong soaking 
capability was placed on the drop. The paper adhered to the surface by wetting 
RESULTS  25 
Marc Wolf – 2003 
forces. On the opposite side 500 nL of capture antibody solution in PBS were 
filled separately into the filling pads. After one minute, 500 nL of BSA were 
added in each pad and allowed to flow for 30 s. All the filling pads were then 
flushed at once with 200 µL of BSA from a pipette and the substrate was taken 
off. Then the substrate was rinsed with Millipore water for 3 s and placed on a 
fresh µFN with the deposited lines of proteins orthogonal to the channels of 
the wafer. 100 µL of BSA solution were placed on the exit pads and a piece of 
clean room paper was placed on top of this drop. 500 nL of sample solution 
were filled into the loading pads and were allowed to flow for 2 minutes. 500 
nL of BSA were then added in each pad and were left flowing for 30 s. The 
area of the loading pads was rinsed with a stream of BSA (1 – 2 mL) from a 
syringe. 5 µL of detection antibodies solution were placed over the loading 
channels for 2 minutes. The loading channels and pads were rinsed with a 
stream of BSA. The BSA was left in the loading pads for 30 s. The substrate 
was taken off and was rinsed 3 s with Millipore water. It was put on a glass 
slide and was covered with a glass cover sheet (0.17 mm thickness), which 
allowed image acquisition with the fluorescence microscope. An overview of 
the single steps is given in Figure 15. 
 
 
Figure 15. The sequence steps of the micromosaic immunoassay. BSA: bovine serum 
albumin, DI: deionized water, FM: fluorescence microscope. 
4.3 Optimization of the Wafer Surface 
To assess the optimal time necessary for the PEG molecules to form a 
continuous monolayer we immersed pieces of silicon wafers covered with a 50 
nm thick layer of Au by in a solution of PEG in Ethanol. In order to keep 
incubation time low we chose a concentration of 10 mM, which is ten times 
higher than the commonly used concentrations.55 After an immersion time of 1 
s, 5 s, 10 s, 30 s, 60 s, 5 min, 10 min, 13 min, respectively, we characterized 
the newly formed monolayer by ellipsometry and contact angle determination. 
For the graphical interpretation of the ellipsometrical data we chose nf = 1.45 
as refractive index of the monolayer in order to calculate its approximate 
thickness. 
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Figure 16. Formation of a PEG-thiol monolayer on a gold surface upon immersion in a 10 
mM solution of PEG-thiols in EtOH.  The thickness of a PEG-thiol layer reaches its saturation 
level of 3.3 nm already after immersion times of ~30 s. This value agrees with the values of 
complete layers... . Completeness of the PEG-thiol monolayer ensures protein repellency and 
favorable wetting properties of the derivatized gold surface. The thickness of the PEG-thiol 
monolayer has been calculated from ellipsometrical data using a refractive index nf = 1.45.  
 
As anticipated, the curve in Figure 16 exhibits the characteristic slope of a 
saturation behaviour termed Langmuir isotherm,72,73 where the desired 
properties of contact angles and layer thickness are clearly attained already 
after a few seconds. For our purposes it was important to have contact angles 
of the PEG monolayer as low as possible (in order to provide rapid filling), 
and a complete monolayer (indicated by its thickness). Complete monolayers 
are important to prevent protein physisorption to uncovered areas of Au. A 
second criterion is the wettability of the surface to provide proper filling of the 
channels. The advancing and receding contact angles of the PEG monolayers 
have been measured six times each one. The angles were Θa = 45.2, Θr = 38.8, 
and Θa = 44.2, Θr = 38.7 for immersion times of 30 s and 10 min respectively. 
There was no significant difference in the contact angles of 30 s and 10 min 
immersion time. An immersion time of 30 s in a solution of 10 mM PEG-
thiols in ethanol is thus sufficient to form a homogenous monolayer of PEG-
thiols on gold. 
When inking a PDMS stamp with thiols and consequently printing it onto a 
surface of Au the layer is usually not form as completely as if it were formed 
by immersion in the corresponding solution of thiols in Ethanol.74 Due to this 
phenomenon, we wanted to investigate the chemical composition of the ECT 
monolayers in the immediate neighbourhood of the filling pads and channels 
of the µFNs, where completion of the imperfect monolayer of ECT by 
molecules of PEG could occur during incubation with PEG solution. X-ray 
photospectroscopy is ideal, because statements about the occurrence of 
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specific isotopes can be made. We measured two individual spots on the same 
piece of wafer, one in a filling pad with a PEG monolayer, another one in a 
distance of 1.5 mm from the border of the filling pad onto where the ECT had 
been printed.  
The X-ray beam was focused to 400 µm. The XPS survey corresponding to the 
derivatization of the fluidic zones with HS-PEG revealed the presence of O 1s 
at 532 eV and two peaks of C 1s at 287.5 eV. The Au 5f1/2 centred at 84 eV 
corresponds to the Au surface underneath the monolayer. The sulphur of the 
HS-PEG molecule, expected at 163 eV, was not visible due to its high 
attenuation by PEG-chain composing the rest of the monolayer. The intensities 
of the O 1s and C 1s peaks were as expected for a poly(ethylene) chain.75 The 
high-resolution spectrum of the C 1s for this surface, revealed only 3% of 
contaminants in the HS-PEG layer indicating that the HS-PEG layer is of very 
high purity. The spectrum obtained next to the filling pad corresponding to the 
region where HS-ECT was microcontact printed revealed 1 type of carbon at 
285 eV and a minor unexpected peak of oxygen at 532 eV. The carbon signal 
corresponds to the alkyl chain of the HS-ECT monolayer and the small oxygen 
signal to the oxygen present in the HS-PEG molecules. These HS-PEG 
molecules were included during the derivatization step of the inside the 
microchannels. Such an insertion is known and has been extensively 
reported.76 Importantly, the inclusion of some HS-PEG molecules in the HS-
ECT monolayer did not compromise the hydrophobic properties of the HS-
ECT monolayer (Figure 17). 
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Figure 17. The XPS spectra of a PEG monolayer inside the filling pad and an ECT monolayer 
outside the filling pad. The PEG monolayer is of very high purity (C 1s ascribed to 
contaminants smaller than 3%). 
 
The wetting pattern was revealed by addition of a small amount of water onto 
the derivatized surface (Figure 18). The water resides in the PEG covered 
hydrophilic channels and pads. 
 
 
Figure 18. The wetting pattern of the thiol derivatized Au-covered wafer was revealed by 
addition of a drop of water. The surface inside the channels and pads, covered with PEG-
thiols, has a low contact angle while the surface outside channels and pads, covered with ECT-
thiols, has a high contact angle with water. The water sought contact with the surface 
derivatized with PEG-thiols in order to minimize its surface free energy. 
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The wetting behaviour of water inside channels and pads can be seen in Figure 
19. Because of the small area of the pads, it was not possible to measure the 
surface contact angle. However, an approximation might be possible by 
observing and interpreting angular changes in the shape of a defined volume of 
liquid inside the pads (Figure 19B).  
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Figure 19. (A) Profiles of water advancing in the draining channels. In some channels, the 
water advances very far as a thin film at the intersection of the channel walls with the bottom 
of the channel. (B) A drop of water inside a filling pad adheres to its edges and forms a contact 
angle with it. 
 
As it would be desirable to perform multiple assays with the same µFN after a 
simple cleaning procedure, we tested different cleaning methods. In Figure 20 
the different approaches of the methods are shown sorted by their 
aggressiveness towards the different surface layers.  
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Figure 20. Different methods of cleaning the wafer surface from proteinaceous remnants vary 
in aggressiveness and remove more or less of the surface layers. Ethanol removes proteins and 
parts of the monolayers (PEG and SAM). Detergents can remove proteins but will stick to the 
monolayers. Sonication can reduce the reaction time. Hexadecane is a lipophile solvent and 
removes monolayers but not proteins from the Au surface. NaOH can tackle proteins. Piranha, 
Ozone and oxygen plasma are strong oxidizers and remove proteins and monolayers. Ar 
sputtering uses kinetic energy to mechanically clean surfaces. I3- can be used to remove the Au 
from the Si-wafer. 
 
Most interesting would be a brief rinse with a non-aggressive solvent as for 
example a detergent-like SDS. Unfortunately the surface of the ECT layer is 
not biocompatible which means that in the current setup of the µMIA, where 
blocking with BSA covers the entire region of the wafer adsorption of bovine 
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albumin to this area occurs. First, this is not desirable because of possible 
contamination of pad contents in subsequent assays performed on the same 
µFN, second and more important, the physisorbed albumin has a significantly 
lower contact angle than ECT layers on gold, which prevents formation of a 
proper wetting pattern with water and thus residing of solutions inside the 
individual pads while filling them. Short exposure to SDS did remove 
proteins. Unfortunately, the PEGs are completely soluble in water and even 
better in Ethanol, which excludes prolonged exposure to either of them if the 
monolayer has not to be destroyed or at least remarkably diminished. To our 
knowledge there does currently not exist a satisfying method to remove 
proteins from ECT-SAMs on gold to receive a well defined and proper 
monolayer surface without damaging it or having to reform it. On the scheme 
in Figure 20 we therefore have to move at least one step lower towards more 
aggressive surface treatments for the removal of the SAMs. Established 
methods for removal of thiol-SAMs on gold are immersion in hexadecane for 
more than 20 min at 60 ºC,77 immersion in a 0.5 M solution of KOH, exposure 
to ozone78 or oxygen plasma.79 KOH is capable of disintegrating Proteins in 
their constituting amino acids by hydrolysis of the amino bonds, but also of 
dissolving Si, even at low concentrations, which is not desirable in our case. 
Hexadecane is not well suited to remove proteins from surfaces and 
investigation of the removal of proteins physisorbed to thiol-SAMs on gold do 
not exist to our knowledge and thorough investigation of this topic would have 
been necessary, which exceeds the scope of this work. A simple means to 
remove proteins as well as SAMs on gold is oxidation. Here, a major partition 
into liquid (e.g. Piranha solution) and gas phase (ozone treatment, O2-plasma) 
oxidizing procedures can be made. Solvents are normally more dangerous in 
handling and prone to accidents than gas handling devices. O2-plasma is a fast, 
simple, and widely used means to oxidize surfaces. The problem with thin 
gold surfaces is their destruction by the applied kinetic energy of the plasma, 
which will be even more accentuated at repeated exposures. Ozone is strongly 
oxidizing and it can be generated easily with UV radiation at two wavelengths. 
Chemical modification of the gold and insertion of oxygen up to a depth of a 
few nm into gold surfaces occurs but importantly no removal of gold from the 
surface. Islands of proposed double layers of alkanethiols have been observed 
on ozone treated gold, but not if the gold was immersed in ethanol before self-
assembly for at least 10 minutes.80 Table 2 summarizes the properties of the 
above-mentioned methods to clean the wafer surface in order to render it 
reusable. 
 
Detergents / EtOH, Sonication Requires much time to remove proteins with low specificity 
(also the thiol layer is partly removed. Detergents adsorb to 
Au and ECT. Poor surface definition results. 
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Piranha Oxidizes the Au on the surface. Repeated exposure leads to 
delamination of Au. 
Hexadecane Does not attack the proteins. Hexadecane needs to be 
removed. 
NaOH Must be concentrated to effectively remove proteins and 
thiols, but high concentrations also dissolve the SiO wafer. 
We also observed delamination of Au, possibly due to 
preexisting microlesions in the surface. 
Ozone Temporarily modifies the Au by introduction of oxygen. 
O-plasma Changes the oxidation state of Au in an undefined manner. 
Ar-sputtering Costly instrumentation and elaborate process, although 
excellent surface definition. Possibly difficulties in cleaning 
the channel walls. 
I3 Removes Au. Wafers need to be coated again. 
Table 2. Key features of alternative methods to clean the wafers after their use in order to 
reuse them. 
 
We made XPS measurements (results not shown) of the surface composition at 
two spots of a µFN. The µFN was prepared as described above, with 
microcontact printing (µCP) of ECT and incubation with PEG in solution, 
incubated with a 1% solution of BSA for 45 min, treated with ozone under a 
UV lamp for 15 min, rinsed with ethanol for 3 s, and derivatized with thiols. 
These spectra showed no significant change in the apparition of their peaks 
compared to the spectra we obtained from thiol-SAMs on gold that was not 
treated with ozone prior to surface derivatization with thiols. We therefore 
conclude that cleaning with ozone as described above provides a means to 
clean easily the surfaces of our µFNs from proteins and thiol-SAMs to allow 
reformation of thiol-SAMs without significant change in their quality.  
4.4 Does Significant Depletion of Capture Antibody Occur inside 
Channels? 
Patterned non-specific adsorption of proteins on surfaces with microfluidic 
networks has been studied well.69,17 In shallow (3 µm) channels, depletion of 
proteins in the channels can be observed at low protein concentrations due to 
loss by adsorption.81 We tried to exclude depletion as a potential signal 
distortion in our experiments. We compared fluorescence intensities of 
patterned lines of αCRP Ab at different distances from the beginning of the 
channels. A solution containing αCRP antibodies at a concentration of 100 µg 
mL-1 was allowed to flow through the channels for 30 s before adding 500 nL 
of 1% BSA solution to each pad for blocking. By experience 500nL of 
solution require about 2 min to flow entirely through the channels. By 
incubating the substrate surface with drops of 50 µg mL-1 CRP and 120 µg 
mL-1 αCRP-FITC each in 1% BSA and for 45 min, the adsorbed stripes of 
αCRP could be detected with the fluorescence microscope. The area of interest 
was focused with 1/32 of excitation energy by insertion of neutral density 
filters in order to minimize photobleaching of fluorophores during this 
process. Focusing took about three seconds for each region. We did not 
measure the bleaching rate at this intensity, but it can be expected to be well 
under 5% of original signal, as we observed a reduction in signal of 20% 
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between first and second exposure, when taking two consequent frames, each 
during 16 s at ¼ of excitation intensity (assuming a linear behaviour of 
photobleaching during the 30 first seconds of illumination). 
Comparison of the fluorescence signal intensity of stripes at different distances 
from their starting point revealed no significant change as would be expected 
for depletion of αCRP antibodies. We can therefore conclude that no depletion 
of αCRP in the channels occurs when a solution of 100 µg mL-1 is allowed to 
flow for at least 30 s through the channels. This is important to establish linear 
correlation between analyte concentration and fluorescence signal intensity.  
4.5 Does Variation of pH Significantly Change Binding Rates? 
Speed of protein adsorption, when non-specific, depends among other factors 
on the properties of surface (hydrophobic/ hydrophilic, surface charge) and on 
the total charge of the proteins. Generalization can not be made, as certain 
proteins, especially larger ones fibrinogen, pyruvat kinase, γ-globulins), seem 
to adsorb both, on hydrophilic and hydrophobic surfaces, whereas smaller 
proteins adsorb only to hydrophobic surfaces.61 However, protein adsorption 
depends also on the total charge of the proteins, which varies with ambient pH. 
In order to evaluate the correlation of mouse IgG1 αCRP adsorption on PDMS 
with pH, we made solutions of αCRP with different pH (acetate 5.0, PBS 6.0, 
PBS 7.0, PBS 8.0, Tris HCl 9.0). Charge of proteins and their adsorption 
behaviour also depend to a certain extent on the buffer used as well as its 
molar concentration.82,83 Therefore, we cannot entirely isolate the pH 
parameter with this experiment. The data obtained revealed no significant 
change of signal with variation of pH at a concentration of 100 µg mL-1 αCRP 
IgG. This conforms to the finding that such variations mainly occur at low IgG 
concentrations.84 We therefore decided to use the standard PBS buffer with a 
pH of 7.2 and a molarity of 150 mMol L-1.  
4.6 Capture and Detection Antibody Concentrations 
Monoclonal antibodies are an expensive good, and one does not want to use 
large quantities of them, when the same result can be obtained with smaller 
ones. Clearly, one expects simple saturation behaviour for the relation of 
signal intensity and concentration of detection antibody, although background 
might impose some troubles at very high concentrations, where BSA does not 
anymore dominate the dynamic equilibrium numerically. Quite differently, the 
variation of capture antibody concentration is more complex. Usually, proteins 
like to extend or flatten themselves on surfaces more or less, depending 
whether they tend to be rigid or flexible and on their concentration in the 
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liquid phase, to e.g. present hydrophobic sections to a hydrophobic surface 
when in hydrophilic medium. Higher concentration in the liquid phase means 
denser packing on surfaces. Considering possible steric hindrance of the 
antigen when confronted with densely packed IgG on a surface, one could 
expect an optimum concentration for capture antibodies to receive maximum 
number of bound antigens, which has also been observed experimentally.14 
Figure 21 presents the results obtained. We chose 100 µg mL-1 of αCRP as 
working concentration for further experiments.  
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Figure 21. Influence of the concentration of αCRP Ab used to capture CRP on PDMS on the 
efficiency of the sandwich immunoassay. (A) The steps of the assay for CRP are denoted by 
arrows. The relevant reagents or buffers are indicated above the arrows; their concentration 
and the duration of the step are indicated below them. The bent arrow indicates the separation 
of the PDMS substrate from the microchannels and its repositioning onto a fresh µFN after 
rotation by 90º. (B) The µFN can be loaded with up to eight different solutions (1 per 
microchannel) before and after rotating the PDMS substrate. There is thus a maximum of 64 
sites of the PDMS that can be exposed to different solutions of proteins. Captured CRP is 
detected with fluorescently-labeled αCRP Abs, which yields a mosaic of fluorescence. All the 
vertical channels except one were filled with solutions of αCRP Abs at different 
concentrations, and the horizontal channels were filled with CRP in PBS at 0.5 (▲), 5 (●) or 
50 µg mL–1 ( ). (C) The mean intensities of the fluorescence signals forming the mosaic are 
plotted against the concentration of αCRP Ab. The lines serve as guides to the eye. 
Figure 22 presents signal dependence on the concentration of detection 
antibodies. The background due to non-specific adsorption increased only 
slightly with 3400 µg mL-1 of αCRP-FITC, which can be explained with the 
decrease of the quotient concentration of BSA over concentration of αCRP-
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FITC. As future working concentration, we chose 120 µg mL-1 of αCRP-FITC. 
This would compensate for dilution effects due to small residues of BSA and 
analyte solution inside the loading pads. 
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Figure 22. Optimization of the concentration of detection Ab in PBS to detect captured CRP. 
(A) αCRP at a concentration of 100 µg mL–1 in PBS was deposited onto PDMS to capture 
CRP from a 5 µg mL–1 solution in PBS. The concentration of αCRP-FITC detection Abs was 
varied. (B) The fluorescence signal varied with the concentration of detection Abs ( ), 
whereas a background fluorescence signal (●) remained constant when no CRP was present in 
the solution. 
4.7 Time Dependency of Analyte Binding 
The binding of the analyte molecules can be expected to be time dependent 
due to stochastic collisions with the specific binding sites of the capture 
antibodies until an equilibrium state has been reached. For details, see the 
remarks on the Scatchard model earlier in this document. As the orientation of 
the analyte molecule also is important, the correct epitope has to be presented 
to the antibody’s binding region, the time until saturation can be increased, 
compared to the simple, not orientation dependent physisorption on surfaces. 
The reasons we want to know the time course are on one hand the want for 
strong signals, even at low concentrations and second the urge to minimize 
inter-assay variances. This second argument can be understood, of one looks at 
the shape of the curve in Figure 23 at t = 40 s and at t = 280 s. At the former 
place, the curve is much steeper than in the latter, which means, that a small 
change dt in incubation time at t = 40 s produces a larger change in signal dI, 
than at t = 240 s. In order to assess the time course of CRP binding to 
physisorbed capture antibodies, we let a 0.1 µg mL-1 CRP solution in BSA 
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flow through the 8 channels on the same wafer for different times (40 s, 80 s, 
120 s, 160 s, 200 s, 240 s and 280 s).  
Introducing the association and dissociation rate constants k1 and k2 into 
equation (5) yields a kinetic representation of the binding dynamics. 
 
   (7) 
 
where t is the time. The amount of bonds forming per time unit increases when 
the concentration [L] rises. This means, that for higher concentrations of CRP, 
the slope of the saturation curve will be much steeper than the one for the 0.1 
µg mL-1 CRP we chose for the experiment. When one intends to measure 
concentrations no smaller than 0.1 µg mL-1 CRP in the samples, the time 
necessary for the capture binding reaction will be around 180 s to reach a 
reasonable level of saturation (more than 80 % approximated by curve fitting 
of the data obtained). 
The equation, which can be used to describe the saturation behaviour, can be 
written as 
 
(8) 
 
where I is the amount of analyte bound, a the amount of analyte bound for t = 
∞ and b a time constant which governs the slope of the curve. 
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Figure 23. Effect of the time on capturing CRP on the fluorescence signal of the sandwich 
immunoassay. (A) The optimal concentrations of αCRP and αCRP-FITC in PBS were 
determined in the previous assays; the concentration of CRP in PBS was 0.1 µg mL–1. (B) 
RESULTS  36 
Marc Wolf – 2003 
Solutions of CRP were flushed in the microchannels for variable durations (vertical lines), and 
the fluorescent signals corresponding to the detection of captured CRP were recorded, 
averaged along the vertical lines and plotted in (C) against the duration of capture. The 
fluorescence saturates as the duration for capture becomes sufficient to occupy a maximum of 
capture sites with CRP. The maximum expected signal is extrapolated from the fit. A capture 
step duration of 180 s is sufficient to achieve ~80% of the maximum signal for the conditions 
selected here. 
 
4.8 Assay Variance and Spot Quality 
The accuracy of an immunoassay depends on some major factors, such as the 
variability of the signals (intra- and inter-assay), the characteristics of the 
reference curve (i.e. binding behaviour of the Abs) and the resolution of the 
signal intensity. The characteristics of the reference curve can be matched to 
requirements by choosing appropriate Abs, while the resolution of the signal 
intensity is limited by the photo-registration device. Especially the variability 
is influenced by multiple, in part environmental, parameters (photobleaching, 
quality of materials, temperature, reaction time, concentrations of reactants) 
that are sensible. It is therefore crucial to minimize the influence of these 
potential noise generators. The fluorophores FITC and TRITC exhibit rapid 
photobleaching. The problem can be minimized with the use of novel 
fluorophores with improved photo-stability, such as Cy™ labels. The 
microfluidic networks have to be inspected microscopically prior to use in 
order to exclude defects and contaminations. The liquids have to be filtered 
prior to use in order to prevent obstruction by microscopic particles (usually 
present in most protein dilutions). The temperature can be held at constant 
levels. The reaction time should neither be shortened nor extended. This is 
difficult when pipetting manually, but the problem could be resolved with 
automatic instrumentation. The manual dilution of reactants should be 
addressed with care.  
We determined the intra-assay variability of a µMIA for CRP (Figure 25A) by 
taking into consideration measures limiting variability. The CRP concentration 
of all the eight samples was 0.1 µg mL-1. The c.v. of the resulting 64 
fluorescence signals was 4.4%. This is sufficient for clinical applications (< 
5%). However, we still see a possible improvement and estimate the minimal 
c.v. of µMIAs to be less than 2%. The quality of the single spots was 
examined at larger magnification. The quality of shape and border (Figure 
25C) as well as the overall signal uniformity, visualized with a horizontal 
profile plot (Figure 25D), of the spots are excellent. Improvements of the spot 
quality would be difficult to obtain and only minimally affect the intra-assay 
signal variability. 
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Figure 24. Quality assessment of the fluorescence signal of a µMIA for CRP. (A) Conditions 
for the detection of CRP were identical for all channels and used (B) FITC-labelled or (C) 
Cy3-labeled αCRP detection Abs. (B) This mosaic has 64 sites with a fluorescent signal 
varying by only 4.4%. (C) This high-resolution fluorescence image reveals the resolution, 
contrast and homogeneity of two adjacent sites of a µMIA. (D) Profile of the fluorescence 
intensity measured along the middle of the two sites shown in (C). These results show the high 
quality of the signals in the micromosaic in terms of inter- and intra-spot variations.  
 
4.9 Reference Curve 
In order to derive the concentration of the analyte from the fluorescence signal 
of test samples a signal-concentration function is needed. This function can be 
approached experimentally with the measurement of fluorescence signals of 
samples with known concentrations of analyte.  
The solvent of reference samples should be identical with the solvent of the 
test samples. This can exclude inaccuracies due to interferences of the solvent 
with the testing method, also described as matrix effect.20 In order to eliminate 
the physiological level of CRP in the reference samples we purified human 
plasma by affinity chromatography. Protein A covered sepharose was 
saturated with rabbit polyclonal αCRP IgG. One mL of human plasma was 
affinity purified. In order to demonstrate the absence of CRP in the purified 
plasma we compared its fluorescence signal with the background signal of a 
control (PBS) in a µMIA. No significant difference between the two signals 
was observed, which confirmed the absence of CRP in the purified plasma. 
We then generated reference samples by spiking the human plasma samples 
with CRP in order to receive CRP concentrations ranging from 0.1 to 10 µg 
mL-1. The reference samples were applied in a µMIA (Figure 25A). The 
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reference curve obtained has a dynamic range from 0.1 to 10 µg mL-1 (Figure 
25B). The concentration ranges of CRP in CHD (0.1 – 0.5 µg mL-1) and SI (10 
– 100 µg mL-1) can be covered with the range of the assay either directly or by 
dilution of the test sample. It therefore seems realistic that the current 
configuration of αCRP antibodies might become integrated in a POC test for 
CRP. 
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Figure 25. Reference curve for CRP-free human plasma spiked with CRP. (A) The 
concentration of CRP added to human plasma samples was the only parameter varied in this 
sandwich immunoassay. (B) The fluorescence signals obtained from the corresponding µMIA 
(not shown) can be fitted with a sigmoid curve. The assay is sensitive enough to cover the 
lower ranges of CRP of CHD and systemic inflammation conditions. 
4.10 Detecting Multiple Markers in Human Plasma Simultaneously 
We set up a simple demonstration of a µMIA for detecting four cardiac 
markers simultaneously, Figure 26. Some of the lines for capture were made 
redundant (Mb, S100α and CRP) and one line served as a negative control 
(PBS). The detection step was performed by filling all loading pads with the 
same cocktail having detection Abs against all putative markers, Figure 26A. 
The prerequisite for performing such combinatorial µMIA is the absence of 
cross reactivity between the different detection Abs and both the capture Abs 
and analytes. It took ~8 min to perform the various steps and another ~2 min 
to separate the PDMS substrate from the µFN, and to rinse and dry it. By 
applying capture Abs against CRP and Abs against cardiac markers to 
different microchannels, the simultaneous detection of different cardiac 
markers was achieved. Figure 26B presents the pattern of an assay for CRP, 
Mb, cTnI, and S100α using αCRP, αMb, αcTnI, and αS100α capture Abs, 
respectively. The samples were solutions of plasma, obtained from healthy 
subjects, to which markers were added. The mosaic of fluorescence in Figure 
RESULTS  39 
Marc Wolf – 2003 
26 shows the expected result: There are no false negative or positive signals 
present in the mosaic, and redundant screening yields equivalent fluorescence 
signals. This indicates that no cross contamination among the microchannels 
and no depletion of Ab or analyte occurred during the assay.  
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Figure 26. Simultaneous detection of cardiac markers in different samples, using a µMIA. (A) 
Four capture Abs (αMb, αcTnI, αS100α, and αCRP) were deposited along horizontal lines of 
the µMIA and used to detect cardiac markers that were added to plasma samples of healthy 
subjects. Captured markers were detected by filling microchannels (vertical direction) with a 
cocktail of fluorescently labelled Abs (αCRP-FITC, αBNP-Cy3, αS100α-Cy3, αMb-FITC and 
αcTnI-Cy3). (B) Fluorescence microscope image, that revealing the micromosaic of binding 
events. As expected, no signal for S100α and BNP was observed due to the absence of either 
S100α in the plasma sample or αBNP capture Ab on the substrate. 
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5 DISCUSSION 
We focused on the optimization of the µMIA method for the quantitative 
detection of markers of disease in human plasma. Critical points for a potential 
clinical applicability of the µMIA method are sensitivity of the assay and 
reproducibility of the results and therefore deserved special interest. We can 
divide the work in six steps as follows. 
First we designed the surface properties of the µFN wafers by covering them 
with gold and selectively functionalizing them with alkane thiols. The quality 
of the thiol monolayers inside and outside the pads of the µFNs was verified 
by ellipsometry and XPS. The storage time of the functionalized wafers before 
their use is limited because the thiol layers on the gold surface oxidize and mix 
by diffusion. This issue is critical for a clinical application and methods to 
circumvent the problem have to be found. On top of the µFNs we put a flow 
promoting sheet which allowed multiple refilling of the loading pads with 
different liquids. The flow of the liquids is driven only by capillary forces. A 
sequential filling of these ‘autonomic’ µFNs to conduct assays has not yet 
been described in the literature. We see an advantage in the passive flow of 
liquids because no external pumping devices are necessary. The flow can still 
be influenced by the physical properties of the µFNs and the flow promotion. 
Second, we minimized factors that could deteriorate the accuracy of the assay. 
Relevant depletion of αCRP capture Abs at a concentration of 0.1 mg mL-1 
was excluded. No relevant changes in the binding behaviour of the Ab binding 
upon pH variations from pH 4 to pH 9 were observed. The assays were 
performed in a chamber of constant relative humidity (> 85%). The liquids for 
the assay were filtered with pore sizes < 0.22 µm in order to exclude 
obstruction of the channels. Third, we evaluated the optimal values of assay 
parameters. With single combinatorial µMIAs we have evaluated the optimal 
concentrations of capture Abs and detection Abs, respectively. The kinetics of 
the analyte binding reaction was analyzed in a single µMIA in order to choose 
the minimal reaction time with acceptable signal intensity. We found that the 
total time required to perform a µMIA is ~8 min. Fourth, we found a low intra-
assay variance (c.v. = 4.4%) and a high quality of the 20 × 20 ym2 spots of the 
assay. Measures to reduce the variance of results could include covered 
channels (evaporation), identical channels in the µFNs (flow speed), 
automated pipetting (temporal and volumetric acuity), and the use of 
photostable fluorophores. Fifth, we produced a reference curve for the 
detection of CRP in human plasma. The dynamic range of the assay (0.03 – 10 
µg mL-1) can cover the concentration ranges that are relevant for the diagnosis 
of CHD (0.1 – 5 µg mL-1) and SI (> 10 µg mL-1). Sixth, we performed a µMIA 
with different cardiac markers in order to demonstrate the suitability of this 
method to detect multiple markers simultaneously. 
With the µMIA multiple markers were detected simultaneously in small 
volumes (~2 µL) within ~8 min. The assay for CRP in human plasma had a 
sensitivity of ~0.03 µg mL-1 and an intra-assay c.v. of 4.4%. Common assay 
methods require at least 200 µL of sample and 2 min for detection of one 
marker.173 A POC test for cardiac markers requires sufficient accuracy and fast 
delivery of results, portability, and easy handling. The test would ideally be 
performed in direct vicinity to the patient in treatment with a drop of venous 
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blood and render results that are significant for further therapeutic pathway 
decisions. With the use of integrated electronics/micromechanics and prepared 
substrates – comparable to test strips174 or integrated systems175 already 
available – these requirements could be met by the µMIA method. The µMIA 
can be extended to contain more than eight channels. This would allow 
measurement of multiple markers of disease and increase sensitivity and 
specificity of laboratory diagnosis.176 Markers for different diseases could 
exclude/ diagnose diseases, while multiple markers for the same disease each 
add little significant information. Of course, there would remain potential 
problems. The selection of markers has to be done carefully with regard to 
possible interactions (that could be excluded with detection of potential 
interacting compounds) and limitations of detection (sensitivity, specificity, 
thermal constraints, storability). In addition, possible interference of 
substances present in the sample must be evaluated. The interference of 
haemoglobin, lipids and bilirubin with immunoassay based diagnostic tests in 
a dose dependent manner was reported177,178,179,180. It is common practice, that 
manufacturers of clinical analyzers specify the allowed maximal concentration 
of known interfering substances to generate sufficiently accurate results.181 A 
mathematical correction algorithm for haemolysed samples was also 
proposed.182 Compared to clinical analyzers utilizing a solid phase 
immunoassay, the immunochemical reaction inside the microfluidic channels 
is virtually identical, the only difference being the lateral flow of the medium. 
In lipaemic samples, the largest particles to count with are chylomicrons 
(~1000nm).183 This is much smaller than the diameter of the microchannels 
(20 µm). Mechanical obstruction of the channels due to microparticles in 
lipaemic samples therefore is unlikely. However, the interference of 
lipoproteins with the immunoreaction (recognition of the antigen from solution 
by the surface immobilized specific antibody) will presumably be the same as 
observed with well plate assays. However, a thorough investigation of this 
matter is a prerequisite prior to a clinical application of the µMIA method. 
An issue to be considered in fluid handling are pathologies associated with 
altered plasma rheological parameters, i.e. viscosity and wetting angles on the 
microchannel surface. The plasma viscosity varies physiologically and, more 
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pronounced, in pathologic states – an increase of 60% and 10% was observed 
in patients presenting with polyarthritis and plasmocytoma, respectively.184 At 
present, we do not know if accurate testing over the whole range of human 
plasma rheological parameters is feasible with one µFN design. This point 
needs to be clarified prior to developing a fluidic design intended for routine 
clinical analyses. 
The evaluation and interpretation of a vast amount of data from measured 
markers would require sophisticated and powerful help on software level. 
Multiple exceptions from rules and potential interactions would have to be 
considered. Emergency alerts could be included for situations that require 
prompt intervention. Diagnostic options and decision trees could be displayed 
and configured. The software would function as an interactive tool for the 
practising physician and require adequate instruction of the users. 
At present, the µMIA method still requires laboratory equipment and scientific 
knowledge. Nevertheless, applications for POC test already exist and the 
experience acquired by clinicians can show their advantages and 
disadvantages and can lead to technical and clinical process optimization. We 
will be able to learn from the errors of the predecessors of the µMIA POC test. 
The next step towards a clinical application of µMIA will be the comparison 
of measurement results obtained with the µMIA method and with a routine 
hospital laboratory method. Proof of concept and further optimization of the 
µMIA method will be two directions of future research that can synergise 
strongly. 
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6 CONCLUSION 
With the µMIA, simultaneous detection of multiple disease markers in human 
plasma is possible. The µMIA works with small sample volumes (100 µL) and 
can produce results within minutes. The results of this work indicate that it 
should be possible to perform quantitative measurements with the µMIA set-
up used here. The µMIA can also be extended to measure dozens of markers in 
dozens of samples simultaneously. This method could suit the requirements 
for medical applications in point-of-care testing arrangements.97,98 Other 
domains for application could include quality assurance, detection of 
biohazards, cellular biology, and environmental testing.  
The demand for low-cost miniaturized test systems to detect biological 
materials (bioassays) has been increasing in the past few years. Moreover, for 
the near future (20 years), various economic studies forecast a substantial 
increase in the market volume of the bioassays segment99. We believe that the 
µMIA remains a challenging candidate in the competitive market of 
miniaturized bioassays. However, in order to make this imaginary scenery 
become reality, the readiness for substantial financial commitments and 
intellectual engagement is crucial. 
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